Nucleic acid aptamers for detecting extracellular vesicles of human lung cancer cell strain A549 and application of nucleic acid aptamers
Patent Information
- Authority / Receiving Office
- CN Β· China
- Current Assignee / Owner
- SOUTHEAST UNIV
- Publication Date
- 2021-10-22
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of biomedicine and clinical medicine, and specifically relates to a nucleic acid aptamer for detecting extracellular vesicles of human lung cancer cell line A549 and an application thereof. Background technique
[0002] Lung cancer is the leading cause of cancer-related death. Globally, it is divided into two histological types: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Non-small cell lung cancer is the most common type of lung cancer, accounting for about 80% of all lung cancers. It has the characteristics of high incidence, complex pathogenesis, difficulty in early detection, and poor treatment effect. Moreover, the prognosis of NSCLC patients largely depends on the stage of the disease. For example, the 5-year survival rate drops from 60% in clinical stage I to 1% in clinical stage IV. Early diagnosis of lung cancer is urgently needed. Therefore, the development of efficient,...